BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced the commercial availability of BEBUCA™ (buprenorphine) buccal film for use in patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE